{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:30:49Z","timestamp":1765279849149},"reference-count":27,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.3892\/ijo.2014.2370","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T08:24:46Z","timestamp":1396859086000},"page":"1886-1894","source":"Crossref","is-referenced-by-count":6,"title":["Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed"],"prefix":"10.3892","volume":"44","author":[{"given":"SUSUMU","family":"TAKEUCHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHIRO","family":"SEIKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RINTARO","family":"NORO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHIE","family":"SOENO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TEPPEI","family":"SUGANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FENFEI","family":"ZOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HARUKA","family":"UESAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NOBUHIKO","family":"NISHIJIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASARU","family":"MATSUMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUJI","family":"MINEGISHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAORU","family":"KUBOTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIHIKO","family":"GEMMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,4,7]]},"reference":[{"key":"key20180107182807_b1-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1164\/ajrccm.157.1.96-11086","article-title":"Environmental exposure to crocidolite and mesothelioma: exposure-response relationships","volume":"157","author":"Hansen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180107182807_b2-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107182807_b3-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of PEM in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107182807_b4-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/bjc.2012.7","article-title":"Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules","volume":"106","author":"Shimokawa","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180107182807_b5-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/jnci\/djm083","article-title":"Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier","volume":"15","author":"Seike","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"key20180107182807_b6-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"12085","DOI":"10.1073\/pnas.0905234106","article-title":"MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers","volume":"21","author":"Seike","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107182807_b7-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2407-6-174","article-title":"Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database","volume":"6","author":"Gemma","year":"2006","journal-title":"BMC Cancer"},{"key":"key20180107182807_b8-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1535-7163.MCT-07-2140","article-title":"Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model","volume":"7","author":"Miyanaga","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key20180107182807_b9-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1158\/1078-0432.CCR-08-0075","article-title":"Expression and gene amplification ofactinin-4 in invasive ductal carcinoma of the pancreas","volume":"14","author":"Kikuchi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107182807_b10-ijo-44-06-1886","first-page":"716","article-title":"Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies","volume":"109","author":"McCarty","year":"1985","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107182807_b11-ijo-44-06-1886","first-page":"1116","article-title":"LY231514, a pyrrolo [2,3-d] pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res"},{"key":"key20180107182807_b12-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/onc.2009.478","article-title":"Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells","volume":"29","author":"Tajima","year":"2010","journal-title":"Oncogene"},{"key":"key20180107182807_b13-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.2009.01358.x","article-title":"Significance of thymidylate synthase for resistance to PEM in lung cancer","volume":"101","author":"Ozasa","year":"2010","journal-title":"Cancer Sci"},{"key":"key20180107182807_b14-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1200\/JCO.2009.25.9275","article-title":"Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with PEM-based chemotherapy","volume":"28","author":"Righi","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107182807_b15-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10555-007-9049-z","article-title":"Molecular basis of antifolate resistance","volume":"26","author":"Assaraf","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107182807_b16-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"e14568","DOI":"10.1371\/journal.pone.0014568","article-title":"Osteopontin expression during early cerebral ischemia-reperfusion in rats: enhanced expression in the right cortex is suppressed by acetaminophen","volume":"6","author":"Baliga","year":"2011","journal-title":"PLoS One"},{"key":"key20180107182807_b17-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tcb.2005.12.005","article-title":"Osteopontin: role in cell signaling and cancer progression","volume":"16","author":"Rangaswami","year":"2006","journal-title":"Trends Cell Biol"},{"key":"key20180107182807_b18-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1158\/1078-0432.CCR-05-0541","article-title":"Osteopontin expression and prognostic significance in non-small cell lung cancer","volume":"18","author":"Donati","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107182807_b19-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1014734930781","article-title":"The role of osteopontin in breast cancer: clinical and experimental studies","volume":"6","author":"Tuck","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"key20180107182807_b20-ijo-44-06-1886","first-page":"2271","article-title":"Osteopontin: possible role in prostate cancer progression","volume":"5","author":"Thalmann","year":"1999","journal-title":"Clin Cancer Res"},{"key":"key20180107182807_b21-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/94.7.513","article-title":"Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling","volume":"94","author":"Agrawal","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"key20180107182807_b22-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.287.13.1671","article-title":"Osteopontin as a potential diagnostic biomarker for ovarian cancer","volume":"287","author":"Kim","year":"2002","journal-title":"JAMA"},{"key":"key20180107182807_b23-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V","article-title":"Co-expression of osteopontin and CD44v9 in gastric cancer","volume":"79","author":"Ue","year":"1998","journal-title":"Int J Cancer"},{"key":"key20180107182807_b24-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107182807_b25-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","article-title":"Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment","volume":"13","author":"Grigoriu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107182807_b26-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/JTO.0b013e3182272294","article-title":"Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma","volume":"11","author":"Hollevoet","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key20180107182807_b27-ijo-44-06-1886","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/PAS.0b013e3181b6bde3","article-title":"Tenascin-X is a novel diagnostic marker of malignant mesothelioma","volume":"33","author":"Yuan","year":"2009","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2370\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T13:31:49Z","timestamp":1515331909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,7]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,4,7]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.3892\/ijo.2014.2370"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2370","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,7]]}}}